Oğul, HayriKızıloğlu, AlperOğul, Yasemin2023-07-262023-07-2620230145-56131942-7522https://doi.org/10.1177/01455613221150121https://hdl.handle.net/20.500.12684/13180Significance Statement Posterior reversible encephalopathy syndrome (PRES) is characterized by variable neurological findings such as headache, deterioration in mental condition, loss of consciousness and visual loss. The disease results with impairment of the cerebral blood flow autoregulation. Ondansetron, serotonin (5HT-3) receptor antagonist, may cause the haemorrhagic PRES.en10.1177/01455613221150121info:eu-repo/semantics/openAccessHaemorrhagic Posterior Reversible Encephalopathy Syndrome; Ondensatron; Magnetic Resonance Imaging; Susceptibility Weighted ImagingSpectrumEditorial365921312-s2.0-85145678471WOS:000906850300001Q3Q3